XML 27 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Net loss $ (126,820) $ (190,274) $ (87,994)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 31,145 24,572 17,743
Loss on disposal of long-lived assets 3,124 666 633
Impairment loss 16,773 0 0
Unrealized and realized (appreciation) depreciation on equity securities and preferred stock (2,586) 58,894 (66,876)
Noncash dividend income (16,756) (7,421) 0
Amortization of premiums on investments 411 1,070 642
Equity in net loss of affiliates 14,283 21,120 8,944
Stock-based compensation expense 41,576 42,202 38,667
Shares issued as payment for services 11,118 10,777 2,169
Shares issued as consideration for license agreement 0 0 59,579
Provision for bad debts 1,217 1,963 1,757
Deferred income taxes (2,528) (3,467) 1,117
Other noncash items (517) 1,662 460
Changes in operating assets and liabilities:      
Restricted cash 0 (6,987) 0
Receivables:      
Trade 740 2,588 (12,138)
Related parties 631 6,804 (11,042)
Notes 0 (42) 0
Other 661 271 5,286
Inventory 663 3,807 (774)
Prepaid expenses and other 492 (932) (2,729)
Other assets (1,436) 2,189 (2,119)
Accounts payable (3,402) 3,618 (3,263)
Accrued compensation and benefits (1,466) (12,402) 10,491
Other accrued liabilities 3,007 9,002 1,593
Deferred revenue (75,337) (25,481) 74,434
Deferred consideration (313) (630) (943)
Related party payables (147) 310 (64)
Other long term liabilities 1,328 146 96
Net cash provided by (used in) operating activities (104,139) (55,975) 35,669
Cash flows from investing activities      
Purchases of investments 0 (75,246) (181,572)
Maturities of investments 174,542 101,987 88,000
Purchases of equity securities, preferred stock, and warrants (1,161) (2,308) (17,080)
Proceeds from sales of equity securities 235 280 0
Acquisitions of businesses, net of cash received 2,054 0 (123,928)
Investments in affiliates (11,189) (11,542) (13,442)
Cash paid in asset acquisition (14,219) (7,244) 0
Purchases of property, plant and equipment (46,666) (31,629) (12,749)
Proceeds from sale of property, plant and equipment 1,636 274 626
Issuances of notes receivable (2,400) (2,964) (600)
Proceeds from repayment of notes receivable 1,500 0 1,500
Net cash provided by (used in) investing activities 104,332 (28,392) (259,245)
Cash flows from financing activities      
Proceeds from issuance of shares in a private placement 13,686 0 0
Proceeds from issuance of shares in public offerings, net of issuance costs 0 0 328,234
Acquisitions of noncontrolling interests (913) 0 (1,566)
Advances from lines of credit 5,906 5,075 15,232
Repayments of advances from lines of credit (6,493) (4,816) (16,944)
Proceeds from long term debt 325 547 81
Payments of long term debt (519) (1,201) (1,564)
Payments of deferred consideration for acquisitions (8,678) (6,705) (6,252)
Proceeds from stock option exercises 980 19,165 14,462
Payment of stock issuance costs (10) 0 0
Net cash provided by financing activities 4,284 12,065 331,683
Effect of exchange rate changes on cash and cash equivalents 1,027 (873) 209
Net increase (decrease) in cash and cash equivalents 5,504 (73,175) 108,316
Cash and cash equivalents      
Beginning of period 62,607 135,782 27,466
End of period 68,111 62,607 135,782
Supplemental disclosure of cash flow information      
Cash paid during the period for interest 617 964 1,195
Cash paid during the period for income taxes 566 10 1,165
Significant noncash financing and investing activities      
Stock received as consideration for collaboration agreements 0 18,766 9,149
Preferred stock received as consideration for collaboration amendments 0 120,000 0
Receivables converted to preferred stock 3,385 0 0
Stock and warrants issued in business combinations 16,997 0 126,863
Stock issued to acquire noncontrolling interests 5,082 0 9,412
Stock issued in asset acquisition 0 4,401 0
Contingent consideration assumed in asset acquisition 0 3,660 0
Stock issued as payment for contingent consideration 0 1,583 0
Noncash dividend to shareholders 22,385 0 172,419
Deferred consideration payable related to acquisition 0 0 1,992
Purchases of equipment included in accounts payable and other accrued liabilities 2,257 652 782
Receivable recorded in anticipation of dissolution of affiliate 2,598 0 0
Transfer of inventory to breeding stock $ 0 $ 1,191 $ 0